MHRA switches tranexamic acid
This article was originally published in The Tan Sheet
Executive Summary
The Medicines and Healthcare products Regulatory Agency switches Cyklo-F to treat heavy menstrual bleeding from prescription to nonprescription status in the U.K. Women aged 18 to 45 years with a self-diagnosed history of heavy bleeding over several consecutive menstrual cycles can now obtain tranexamic acid from a pharmacist without a prescription, the U.K. regulator announced March 31